Profile http://med.stanford.edu/profiles/Lorrin_Koran/ Email this page Printer friendly version

Key Documents

Lorrin Koran

Emeritus Faculty, Acad Council, Psychiatry & Behavioral Science

Contact Information

Clinical Offices

OCD Clinic 401 Quarry Rd MC 5723 Stanford, CA 94305
Telephone Work (650) 723-2423 Fax (650) 725-0363
Academic Offices

Personal Information
Email lkoran@stanford.edu
Not for medical emergencies or patient use

Clinical Focus

Psychiatry
Trichotillomania
skin picking
compulsive buying

Administrative Appointments

Director, Stanford OCD Clinic , (1990– present )

Honors and Awards

Outstanding Achievement Award, Northern California Psychiatric Society (2004)
Distinguished Life Fellow, American Psychiatric Association (2003)
M.D., cum laude, Harvard Medical School (1966)

Professional Education

Board Certification: Psychiatry, American Board of Psychiatry and Neurology (1973)
Stanford University Medical Center (1970) CA
UCLA Medical Center (1967) CA
Harvard Medical School (1966) MA
M.D., Harvard Medical School (1966)

Community & International Work

OCD Research, Florence, Italy More »

Web Site Links

OCD Research Program

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.

Consulting: Forest Pharmaceuticals Speakers Bureau

Research Interests

1. Novel drug treatments for treatment-resistant obsessive-compulsive disorder (OCD).

2. Novel drug treatments for major depression

3. Drug treatments for impulse control disorders

Clinical Trials

Open label trial of aripiprazole in Trichotillomania. Recruiting
Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction Recruiting
Dextro-Amphetamine versus Caffeine in Treatment-resistant OCD Completed
Duloxetine for the Treatment of Dysthymia Completed
Study of SEP-225441 in Subjects with Generalized Anxiety Disorder No longer recruiting

Publications

Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. Koran LM, Aboujaoude E, Gamel NN. J Clin Psychiatry. 2009;
The prevalence of body dysmorphic disorder in the United States adult population. Koran LM, Abujaoude E, Large MD, Serpe RT. CNS Spectr. 2008; 13 (4): 316-22
Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients. Glick ID, Poyurovsky M, Ivanova O, Koran LM. J Clin Psychiatry. 2008; 69 (12): 1856-9
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuation. Koran LM, Aboujaoude EN, Gamel NN. J Clin Psychiatry. 2007; 68 (3): 422-7
Duloxetine treatment of dysthymia and double depression: an open-label trial. Koran LM, Aboujaoude EN, Gamel NN. J Clin Psychiatry. 2007; 68 (5): 761-5
Escitalopram for compulsive buying disorder: a double-blind discontinuation study. Koran LM, Aboujaoude EN, Solvason B, Gamel NN, Smith EH. J Clin Psychopharmacol. 2007; 27 (2): 225-7
Estimated prevalence of compulsive buying behavior in the United States. Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT. Am J Psychiatry. 2006; 163 (10): 1806-12
Potential markers for problematic internet use: a telephone survey of 2,513 adults. Aboujaoude E, Koran LM, Gamel N, Large MD, Serpe RT. CNS Spectr. 2006; 11 (10): 750-5
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. Ninan PT, Koran LM, Kiev A, Davidson JR, Rasmussen SA, Zajecka JM, Robinson DG, Crits-Christoph P, Mandel FS, Austin C. J Clin Psychiatry. 2006; 67 (1): 15-22
Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder. Koran LM, Aboujaoude E, Ward H, Shapira NA, Sallee FR, Gamel N, Elliott M. J Clin Psychopharmacol. 2006; 26 (1): 79-83
Obsessive-compulsive disorder (OCD) with schizotypy vs. schizophrenia with OCD: diagnostic dilemmas and therapeutic implications. Poyurovsky M, Koran LM. J Psychiatr Res. 2005; 39 (4): 399-408
Memantine for treatment-resistant OCD. Poyurovsky M, Weizman R, Weizman A, Koran L. Am J Psychiatry. 2005; 162 (11): 2191-2
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. J Neuropsychiatry Clin Neurosci. 2005; 17 (4): 472-7
Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study. Bogan AM, Koran LM, Chuong HW, Vapnik T, Bystritsky A. J Clin Psychiatry. 2005; 66 (1): 73-9
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN. J Clin Psychiatry. 2005; 66 (4): 515-20
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M. J Clin Psychiatry. 2005; 66 (3): 353-9
Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. Zohar J, Kennedy JL, Hollander E, Koran LM. J Clin Psychiatry. 2004; 65 Suppl 14 18-21
Overview of Kleptomania and Phenomenological Description of 40 Patients. Aboujaoude E, Gamel N, Koran LM. Prim Care Companion J Clin Psychiatry. 2004; 6 (6): 244-247
A case of kleptomania correlating with premenstrual dysphoria. Aboujaoude E, Gamel N, Koran LM. J Clin Psychiatry. 2004; 65 (5): 725-6
Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation. Koran LM, Chuong HW, Bullock KD, Smith SC. J Clin Psychiatry. 2003; 64 (7): 793-8
A 1-year naturalistic follow-up of patients with compulsive shopping disorder. Aboujaoude E, Gamel N, Koran LM. J Clin Psychiatry. 2003; 64 (8): 946-50
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, Klein DN, Trivedi MH, Arnow B, Keitner G, Kornstein SG, Keller MB. Psychopharmacol Bull. 2003; 37 (4): 73-87
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. J Clin Psychiatry. 2003; 64 (6): 640-7
Venlafaxine in treatment-resistant obsessive-compulsive disorder. Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. J Clin Psychiatry. 2003; 64 (5): 546-50
Treatment non-response in OCD: methodological issues and operational definitions. Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J. Int J Neuropsychopharmacol. 2002; 5 (2): 181-91
Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial. Pallanti S, Quercioli L, Koran LM. J Clin Psychiatry. 2002; 63 (9): 796-801
Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Koran LM, Hackett E, Rubin A, Wolkow R, Robinson D. Am J Psychiatry. 2002; 159 (1): 88-95
Medical disorders among patients admitted to a public-sector psychiatric inpatient unit. Koran LM, Sheline Y, Imai K, Kelsey TG, Freedland KE, Mathews J, Moore M. Psychiatr Serv. 2002; 53 (12): 1623-5
Refractory obsessive-compulsive disorder: state-of-the-art treatment. Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, Ravizza L, Benkelfat C, Saxena S, Greenberg BD, Sasson Y, Zohar J. J Clin Psychiatry. 2002; 63 Suppl 6 20-9
Citalopram treatment of compulsive shopping: an open-label study. Koran LM, Bullock KD, Hartston HJ, Elliott MA, D'Andrea V. J Clin Psychiatry. 2002; 63 (8): 704-8
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Hirschfeld RM, Dunner DL, Keitner G, Klein DN, Koran LM, Kornstein SG, Markowitz JC, Miller I, Nemeroff CB, Ninan PT, Rush AJ, Schatzberg AF, Thase ME, Trivedi MH, Borian FE, Crits-Christoph P, Keller MB. Biol Psychiatry. 2002; 51 (2): 123-33
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W. Arch Gen Psychiatry. 2002; 59 (3): 233-9
Fluoxetine in pathologic skin-picking: open-label and double-blind results. Bloch MR, Elliott M, Thompson H, Koran LM. Psychosomatics. 2001 Jul-Aug; 42 (4): 314-9
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder. Koran LM, Pallanti S, Quercioli L. Eur Neuropsychopharmacol. 2001; 11 (2): 169-72
Sertraline versus imipramine to prevent relapse in chronic depression. Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB. J Affect Disord. 2001; 65 (1): 27-36
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Russell JM, Koran LM, Rush J, Hirschfeld RM, Harrison W, Friedman ES, Davis S, Keller M. Depress Anxiety. 2001; 13 (1): 18-27
Mirtazapine treatment of obsessive-compulsive disorder. Koran LM, Quirk T, Lorberbaum JP, Elliott M. J Clin Psychopharmacol. 2001; 21 (5): 537-9
The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Fireman B, Koran LM, Leventhal JL, Jacobson A. Am J Psychiatry. 2001; 158 (11): 1904-10
Lost human capital from early-onset chronic depression. Berndt ER, Koran LM, Finkelstein SN, Gelenberg AJ, Kornstein SG, Miller IM, Thase ME, Trapp GA, Keller MB. Am J Psychiatry. 2000; 157 (6): 940-7
Pharmacotherapy of obsessive-compulsive disorder in a health maintenance organization. Koran LM, Leventhal JL, Fireman B, Jacobson A. Am J Health Syst Pharm. 2000; 57 (21): 1972-8
Quality of life in obsessive-compulsive disorder. Koran LM, Psychiatr Clin North Am. 2000; 23 (3): 509-17
Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder. Koran LM, Ringold AL, Elliott MA. J Clin Psychiatry. 2000; 61 (7): 514-7
Citalopram and sexual side effects of selective serotonin reuptake inhibitors. Pallanti S, Koran LM. Am J Psychiatry. 1999; 156 (5): 796
Citalopram for treatment-resistant obsessive-compulsive disorder. Pallanti S, Quercioli L, Paiva RS, Koran LM. Eur Psychiatry. 1999; 14 (2): 101-6
Hoarding in obsessive-compulsive disorder: a report of 20 cases. Winsberg ME, Cassic KS, Koran LM. J Clin Psychiatry. 1999; 60 (9): 591-7
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM. J Clin Psychiatry. 1998; 59 (11): 598-607
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ. J Clin Psychiatry. 1998; 59 (12): 669-75
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W. JAMA. 1998; 280 (19): 1665-72
Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks. Sallee FR, Koran LM, Pallanti S, Carson SW, Sethuraman G. Biol Psychiatry. 1998; 44 (3): 220-7
Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. Koran LM, Pallanti S, Paiva RS, Quercioli L. Eur Neuropsychopharmacol. 1998; 8 (2): 121-6
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. Rush AJ, Koran LM, Keller MB, Markowitz JC, Harrison WM, Miceli RJ, Fawcett JA, Gelenberg AJ, Hirschfeld RM, Klein DN, Kocsis JH, McCullough JP, Schatzberg AF, Thase ME. J Clin Psychiatry. 1998; 59 (11): 589-97
Microbial removal of alkanes from dilute gaseous waste streams: kinetics and mass transfer considerations. Barton JW, Klasson KT, Koran LJ, Davison BH. Biotechnol Prog. 1997 Nov-Dec; 13 (6): 814-21
A 2-year study of sertraline in the treatment of obsessive-compulsive disorder. Rasmussen S, Hackett E, DuBoff E, Greist J, Halaris A, Koran LM, Liebowitz M, Lydiard RB, McElroy S, Mendels J, O'Connor K. Int Clin Psychopharmacol. 1997; 12 (6): 309-16
Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. Koran LM, Sallee FR, Pallanti S. Am J Psychiatry. 1997; 154 (3): 396-401
Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. Williams KE, Koran LM. J Clin Psychiatry. 1997; 58 (7): 330-4; quiz 335-6
The undertreatment of dysthymia. Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T, Halbreich U. J Clin Psychiatry. 1997; 58 (2): 59-65
Fluoxetine serum levels are unrelated to outcome in obsessive-compulsive disorder. Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S. Am J Psychiatry. 1997; (154:): 396-401
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Thase ME, Fava M, Halbreich U, Kocsis JH, Koran L, Davidson J, Rosenbaum J, Harrison W. Arch Gen Psychiatry. 1996; 53 (9): 777-84
Quality of life for patients with obsessive-compulsive disorder. Koran LM, Thienemann ML, Davenport R. Am J Psychiatry. 1996; 153 (6): 783-8
Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder? Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S. Am J Psychiatry. 1996; 153 (11): 1450-4
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder? Koran LM, Mueller K, Maloney A. J Clin Psychopharmacol. 1996; 16 (3): 253-4
Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group. Small GW, Birkett M, Meyers BS, Koran LM, Bystritsky A, Nemeroff CB. J Am Geriatr Soc. 1996; 44 (10): 1220-5
Electroconvulsive therapy. Koran LM, Psychiatr Serv. 1996; 47 (1): 23
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA. J Clin Psychopharmacol. 1996; 16 (2): 121-9
Predicting response to fluoxetine in geriatric patients with major depression. Koran LM, Hamilton SH, Hertzman M, Meyers BS, Halaris AE, Tollefson GD, Downs JM, Folks DG, Jeste DV, Lazarus LW. J Clin Psychopharmacol. 1995; 15 (6): 421-7
Treating obsessive-compulsive disorder with serotonin reuptake inhibitors. Koran LM, Eur. Neuropsychopharmacol. 1995; 3 (5): 162-163
Comparing the cost effectiveness of psychiatric treatments: bulimia nervosa. Koran LM, Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn S, Bruce B, Perl M, Kraemer HC. Psychiatry Res. 1995; 58 (1): 13-21
Psychiatrists' patients. Koran LM, Psychiatr Serv. 1995; 46 (9): 873
Do soft signs predict treatment outcome in obsessive-compulsive disorder? Thienemann M, Koran LM. J Neuropsychiatry Clin Neurosci. 1995; 7 (2): 218-22
Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K. Arch Gen Psychiatry. 1995; 52 (4): 289-95
A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Greist JH, Jefferson JW, Kobak KA, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowtiz MR, Lydiard B. Int Clin Psychopharmacol. 1995; 10 (2): 57-65
Maximizing clinical revenues of psychiatric consultation-liaison services. An economic commentary. Koran LM, Foley T. Psychosomatics. 1994 Jul-Aug; 35 (4): 333-40
A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. Arch Gen Psychiatry. 1994; 51 (7): 559-67
Continuation treatment of OCD: double-blind and open-label experience with fluoxetine. Tollefson GD, Birkett M, Koran L, Genduso L. J Clin Psychiatry. 1994; 55 Suppl 69-76; discussion 77-8
Intravenous clomipramine for obsessive-compulsive disorder. Koran LM, Faravelli C, Pallanti S. J Clin Psychopharmacol. 1994; 14 (3): 216-8
One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, Koran LM. J Clin Psychiatry. 1994; 55 (5): 179-83
Fluoxetine for isolated sleep paralysis. Koran LM, Raghavan S. Psychosomatics. 1993 Mar-Apr; 34 (2): 184-7
Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, Bruce B, Perl M, Koran LM. Am J Psychiatry. 1992; 149 (1): 82-7
A national study of psychiatrists' professional activities. Dorwart RA, Chartock LR, Dial T, Fenton W, Knesper D, Koran LM, Leaf PJ, Pincus H, Smith R, Weissman S. Am J Psychiatry. 1992; 149 (11): 1499-505
Fluoxetine for trichotillomania: an open clinical trial. Koran LM, Ringold A, Hewlett W. Psychopharmacol Bull. 1992; 28 (2): 145-9
Funding consultation-liaison psychiatry via Medicare screening. Koran LM, Gen Hosp Psychiatry. 1992; 14 (1): 7-14
Effects of ovariectomy and estrogen replacement on dye coupling among rat supraoptic nucleus neurons. Hatton GI, Yang QZ, Koran LE. Brain Res. 1992; 572 (1-2): 291-5
A profile of academic medical-psychiatric units. Harsch HH, Koran LM, Young LD. Gen Hosp Psychiatry. 1991; 13 (5): 291-5
Time course of salamander spinal cord regeneration and recovery of swimming: HRP retrograde pathway tracing and kinematic analysis. Davis BM, Ayers JL, Koran L, Carlson J, Anderson MC, Simpson SB. Exp Neurol. 1990; 108 (3): 198-213
Medical evaluation of psychiatric patients. I. Results in a state mental health system. Koran LM, Sox HC, Marton KI, Moltzen S, Sox CH, Kraemer HC, Imai K, Kelsey TG, Rose TG, Levin LC. Arch Gen Psychiatry. 1989; 46 (8): 733-40
A medical algorithm for detecting physical disease in psychiatric patients. Sox HC, Koran LM, Sox CH, Marton KI, Dugger F, Smith T. Hosp Community Psychiatry. 1989; 40 (12): 1270-6
House staff well-being. Koran LM, Litt IF. West J Med. 1988; 148 (1): 97-101
Detecting physical disease in psychiatric patients. Koran LM, Sox HC, Sox CH, Marton KI. Med Care. 1987; 25 (12 Suppl): S99
Mobile medical screening teams for public programs. Koran LM, Moltzen S, Sox HC, Marton KI. Hosp Community Psychiatry. 1984; 35 (11): 1151-2
Detecting physical illness in patients with mental disorders. Hoffman RS, Koran LM. Psychosomatics. 1984; 25 (9): 654-60
Changing hospital work environments: an example of a burn unit. Koran LM, Moos RH, Moos B, Zasslow M. Gen Hosp Psychiatry. 1983; 5 (1): 7-13
Recruitment of institutional psychiatrists for the 50 states. Koran LM, Chinn F, Flores S. Soc Sci Med. 1983; 17 (13): 889-96
Lithium prophylaxis of prednisone psychosis: a case report. Goggans FC, Weisberg LJ, Koran LM. J Clin Psychiatry. 1983; 44 (3): 111-2
Psychiatrists' distribution across the 50 states, 1978. Koran LM, Arch Gen Psychiatry. 1981; 38 (10): 1155-9
Mental health expenditures in California counties. Koran LM, Meinhardt K. Am J Psychiatry. 1981; 138 (7): 936-40
Psychiatric manpower ratios. A beguiling numbers game? Koran LM, Arch Gen Psychiatry. 1979; 36 (13): 1409-15
Psychosocial considerations are compatible with the biomedical model. Gonda TA, Koran LM. Man Med. 1979; 4 (4): 279-85
Patients' reactions to psychiatric consultation. Koran LM, Van Natta J, Stephens JR, Pascualy R. JAMA. 1979; 241 (15): 1603-5
Evaluation of a videotape technique for measuring clinical psychiatric skills of medical students. Tardiff K, Redfield J, Koran LM. J Med Educ. 1978; 53 (5): 438-41
Teaching medical students about observer variation. Koran LM, Hahn PM, Varma AA, White L. J Med Educ. 1978; 53 (2): 141-4
Organic disease mistakenly diagnosed as psychiatric. Saravay SM, Koran LM. Psychosomatics. 1977; 18 (2): 6-11
gamma-Aminobutyric-acid deficiency in schizophrenia. Koran LM, Lancet. 1976; 2 (7993): 1025
Mental health services in the public and private sectors. Koran LM, Am J Psychiatry. 1976; 133 (9): 1052-7
Increasing the reliability of clinical data and judgments. Koran LM, Ann Clin Res. 1976; 8 (2): 69-73
Clinical skills. Quantitative measurement. Wiener SL, Koran L, Mitchell P, Schattner G, Fierstein J, Hotchkiss E. N Y State J Med. 1976; 76 (4): 610-2
Controversy in medicine and psychiatry. Koran LM, Am J Psychiatry. 1975; 132 (10): 1064-6
The reliability of clinical methods, data and judgments (first of two parts). Koran LM, N Engl J Med. 1975; 293 (13): 642-6
Letter: Public hysteria and medical practice. Koran L, Fink M, Miller MG. JAMA. 1975; 232 (11): 1126
The reliability of clinical methods, data and judgments (second of two parts). Koran LM, N Engl J Med. 1975; 293 (14): 695-701
Early termination from group psychotherapy. Koran LM, Costell RM. Int J Group Psychother. 1973; 23 (3): 346-59
Heroin maintenance for heroin addicts: issues and evidence. Koran LM, N Engl J Med. 1973; 288 (13): 654-60
Compatibility and cohesiveness in group psychotherapy. Costell RM, Koran LM. J Nerv Ment Dis. 1972; 155 (2): 99-104
[Results in treatment of narcotic drug addicts] Koran LN, Bull Soc Sci Med Grand Duche Luxemb. 1972; 109 (1): 77-81
[Treatment of drug addicts with narcotic and non-narcotic drugs] Koran LM, Bull Soc Sci Med Grand Duche Luxemb. 1972; 109 (1): 67-73
Psychiatry in mainland China: history and recent status. Koran LM, Am J Psychiatry. 1972; 128 (8): 970-8
Psychiatry in mainland China: additional sources. Kleinman AM, Ravitz LJ, Koran LM. Am J Psychiatry. 1972; 129 (4): 482-4
Field dependence in manic-depressive patients. Koran LM, Maxim PE. J Nerv Ment Dis. 1972; 155 (3): 205-8